Cargando…

Long non-coding RNA MIR4435-2HG/microRNA-125a-5p axis is involved in myocardial ischemic injuries

This study aimed to investigate whether and how long non-coding RNA (lncRNA) MIR4435-2 host gene (MIR4435-2HG) involved in acute myocardial ischemia/reperfusion (I/R). Blood samples were collected from acute myocardial infarction (AMI) patients to detect MIR4435-2HG expression. In vivo myocardial I/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiuling, Ren, Lina, Chen, Shuai, Tao, Yanli, Zhao, Dandan, Wu, Chunwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208505/ https://www.ncbi.nlm.nih.gov/pubmed/35475469 http://dx.doi.org/10.1080/21655979.2022.2051259

Ejemplares similares

Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer
por: Hu, Zhiquan, et al.
Publicado: (2022)

Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis
por: Dong, Xinhua, et al.
Publicado: (2020)

LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
por: Ghasemian, Majid, et al.
Publicado: (2022)

LncRNA MIR4435‐2HG functions as a ceRNA against miR‐125a‐5p and promotes neuroglioma development by upregulating TAZ
por: Shen, Wangzhen, et al.
Publicado: (2021)

LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis
por: Xiao, Yu, et al.
Publicado: (2019)

LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis
por: Zhu, Lijuan, et al.
Publicado: (2020)

Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils
por: Yu, Hongfei, et al.
Publicado: (2022)

Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review
por: Chen, Zhou, et al.
Publicado: (2023)

Long non-coding RNA MIR4435-2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR-383-5p/RBM3 axis
por: Wang, Shu, et al.
Publicado: (2021)

LncRNA MIR4435-2HG inhibits the progression of osteoarthritis through miR-510-3p sponging
por: Liu, Yingli, et al.
Publicado: (2020)

LncRNA MIR4435‐2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR‐1224‐5p/TGFBR2 axis
por: Xu, Hongchao, et al.
Publicado: (2020)

MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
por: Zhong, Chenming, et al.
Publicado: (2022)

The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a
por: Kong, Qinglei, et al.
Publicado: (2019)

lncRNA MIR4435-2HG promotes the progression of liver cancer by upregulating B3GNT5 expression
por: Zhu, Yungang, et al.
Publicado: (2022)

Downregulation of long non-coding RNA MR4435-2HG suppresses breast cancer progression via the Wnt/β-catenin signaling pathway
por: Chen, Deqin, et al.
Publicado: (2021)

lncRNA MIR4435-2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF-β1
por: Zhang, Hui, et al.
Publicado: (2019)

LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1
por: Luo, Ping, et al.
Publicado: (2020)

lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression
por: Yang, Tao, et al.
Publicado: (2022)

lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
por: Zhu, Kai, et al.
Publicado: (2020)

LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
por: Wang, Haiyong, et al.
Publicado: (2019)

M2 Macrophage-Derived Exosomal lncRNA MIR4435-2HG Promotes Progression of Infantile Hemangiomas by Targeting HNRNPA1
por: Li, Zhiyu, et al.
Publicado: (2023)

MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages
por: Li, Chaofeng, et al.
Publicado: (2022)

Long non-coding RNA MIR22HG inhibits glioma progression by downregulating microRNA-9/CPEB3
por: He, Yanli, et al.
Publicado: (2021)

Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2021)

Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis
por: Gao, Li-Fei, et al.
Publicado: (2021)

N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2′-O methylation
por: Zhu, Yiqing, et al.
Publicado: (2023)

MiR-4435 is an UQCRB-related circulating miRNA in human colorectal cancer
por: Hong, Ji Won, et al.
Publicado: (2020)

Knockdown of MIR4435-2HG Suppresses the Proliferation, Migration and Invasion of Cervical Cancer Cells via Regulating the miR-128-3p/MSI2 Axis in vitro
por: Wang, Ruijing, et al.
Publicado: (2020)

Hepatic stellate cell‐released CXCL1 aggravates HCC malignant behaviors through the MIR4435‐2HG/miR‐506‐3p/TGFB1 axis
por: Li, Shaling, et al.
Publicado: (2022)

LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder
por: Pei, Lu, et al.
Publicado: (2023)

Fusobacterium nucleatum promotes epithelial‐mesenchymal transiton through regulation of the lncRNA MIR4435‐2HG/miR‐296‐5p/Akt2/SNAI1 signaling pathway
por: Zhang, Shuwei, et al.
Publicado: (2020)

Knockdown of long non-coding MIR210HG inhibits cell proliferation, migration, and invasion in hepatoblastoma via the microRNA-608–FOXO6 axis
por: Duan, Yuhe, et al.
Publicado: (2021)

mi-R4435-2HG promotes proliferation and inhibits apoptosis of cancer cells in ovarian carcinoma by upregulating ROCK2
por: Hu, Jinghui, et al.
Publicado: (2020)

Long non-coding RNA miR155HG silencing restrains ovarian cancer progression by targeting the microRNA-155-5p/tyrosinase-related protein 1 axis
por: Wen, Aiping, et al.
Publicado: (2021)

Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis
por: Liu, Yadong, et al.
Publicado: (2022)

The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer
por: Ke, Dong, et al.
Publicado: (2017)

LncRNA miR143HG Up-Regulates p53 In Endometrial Carcinoma By Sponging miR-125a
por: Shi, Fan, et al.
Publicado: (2019)

Knockdown of lncRNA MIR4435-2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK/AKT/β-catenin signaling pathway
por: Xing, Pengyi, et al.
Publicado: (2021)

The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotype
por: Montes, Marta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i2c1j75se9rnt55s9g49t637dd